TRISALUS LIFE SCIENCES INC (TLSI) Stock Earnings & Estimates
NASDAQ:TLSI - US89680M1018 - Common Stock
4.99 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 18.511M | 29.431M 58.99% | 46.144M 56.79% | 71.13M 54.15% | 101.77M 43.08% | 129.07M 26.83% | 175.86M 36.25% | 206.6M 17.48% | 299.88M 45.15% | 399.48M 33.21% | ||
| EBITDA YoY % growth | N/A | -53.791M | -35.421M 34.15% | -13.617M 61.56% | 510K 103.75% | 11.424M 2,140.00% | 31.212M 173.21% | 43.248M 38.56% | N/A | N/A | N/A | |
| EBIT YoY % growth | -2.75M 9.54% | -54.475M -1,880.91% | -36.165M 33.61% | -23.64M 34.63% | -1.792M 92.42% | 17.072M 1,052.47% | 36.471M 113.63% | 57.067M 56.47% | 121.66M 113.19% | 204.46M 68.06% | 292.8M 43.21% | |
| Operating Margin | N/A | -294.28% | -122.88% | -51.23% | -2.52% | 16.78% | 28.26% | 32.45% | 58.89% | 68.18% | 73.30% | |
| EPS YoY % growth | N/A | N/A | -1.33 43.06% | -0.82 38.54% | -0.12 85.49% | 0.24 306.45% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.15 -22.19% | -0.10 75.46% | -0.04 89.54% | 0.00 99.24% | 0.02 111.13% | 0.04 143.64% |
| Revenue Q2Q % growth | 11.948M 62.58% | 13.436M 62.64% | 15.954M 74.04% | 18.02M 60.71% | 19.381M 62.21% | 21.244M 58.11% |
| EBITDA Q2Q % growth | -4.38M 46.51% | -2.353M 65.58% | -2.652M 62.95% | 408K 105.83% | 612K 113.97% | 2.346M 199.71% |
| EBIT Q2Q % growth | -5.246M 39.97% | -3.445M 54.56% | -804.78K 89.02% | 870.06K 111.87% | 1.835M 134.98% | 3.306M 195.97% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.27 -28.57% | -0.22 | -0.05 | -21.11% |
| Q1 2025 Q2Q % growth | -0.39 35.00% | -0.22 | -0.17 | -73.80% |
| Q4 2024 Q2Q % growth | -0.40 74.36% | -0.32 | -0.08 | -23.56% |
| Q3 2024 Q2Q % growth | -0.12 | -0.35 | 0.23 | 66.00% |
| Q2 2024 Q2Q % growth | -0.21 | -0.50 | 0.29 | 58.27% |
| Q1 2024 Q2Q % growth | -0.60 | -0.66 | 0.06 | 9.50% |
| Q4 2023 Q2Q % growth | -1.56 | -0.70 | -0.86 | -121.65% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 11.213M 52.27% | 10.906M | 307K | 2.81% |
| Q1 2025 Q2Q % growth | 9.167M 41.97% | 9.216M | -49K | -0.53% |
| Q4 2024 Q2Q % growth | 8.261M 44.40% | 8.278M | -17K | -0.21% |
| Q3 2024 Q2Q % growth | 7.349M 41.52% | 7.541M | -192K | -2.55% |
| Q2 2024 Q2Q % growth | 7.364M 59.67% | 7.032M | 332K | 4.72% |
| Q1 2024 Q2Q % growth | 6.457M | 6.302M | 155K | 2.46% |
| Q4 2023 Q2Q % growth | 5.721M | 5.562M | 159K | 2.86% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 13.99% | -11.81% | 5.24% | -32.94% |
| Revenue | 0.54% | 0.29% | 0.9% | 1.07% |